Identifying and managing sources of pain and distress in children with neurological impairment.
Hauer
Julie
J
Division of Pediatrics Palliative Care, Dana-Faber Cancer Institute, Boston, MA, USA. julie_hauer@dfci.havard.edu
D018759:Adrenergic Uptake Inhibitors / Q000627:therapeutic use; D000316:Adrenergic alpha-Agonists; D000700:Analgesics / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002648:Child; D019988:Children with Disabilities; D006801:Humans; D006930:Hyperalgesia; D009422:Nervous System Diseases / Q000150:complications*; D010146:Pain / Q000175:diagnosis* / Q000188:drug therapy* / Q000503:physiopathology; D010147:Pain Measurement; D012702:Serotonin Antagonists / Q000627:therapeutic use
D018759:Adrenergic Uptake Inhibitors; D000316:Adrenergic alpha-Agonists; D000700:Analgesics; D002121:Calcium Channel Blockers; D012702:Serotonin Antagonists